Publication Ethics

1) Plagiarism & Text Recycling

• Manuscripts must be original, not published or under consideration elsewhere; sources must be cited accurately.
• Similarity is screened using detection software. Indicative threshold: ≤ ~15% overall (excluding references and standard methods with proper citation); higher matches are evaluated case-by-case.
• Plagiarism, self-plagiarism, redundant/duplicate publication, and undisclosed translation are prohibited.

2) Authorship & Contributorship

• Authorship follows ICMJE criteria (substantial contribution; drafting/revision; final approval; accountability).
• CRediT taxonomy is required to delineate author roles (e.g., Conceptualization, Methodology, Data Curation, Formal Analysis, Writing, Supervision, Funding Acquisition).
• Post-submission authorship changes require written consent from all authors, justification, and editorial approval.

3) Conflicts of Interest & Funding

• All authors, editors, and reviewers must disclose financial or personal relationships that could be perceived to influence the work.
• Report funding sources and sponsor roles. SHMW may request the ICMJE COI form where appropriate.
• Editors/reviewers with conflicts are recused from handling/reviewing a manuscript.

4) Peer Review & Reviewer Conduct

• SHMW operates double-blind peer review, typically with at least two independent experts.
• Reviewers provide objective, constructive, and timely reports; treat submissions as confidential; and must not use unpublished information for personal advantage.
• Concerns about ethics or possible misconduct should be reported confidentially to the editor.

5) Data Integrity, Availability & Reproducibility

• Report methods and results transparently to allow verification and replication.
• Include a Data Availability Statement (repository/DOI, controlled access, or justified restrictions).
• Retain raw data/code/analysis scripts for a reasonable period (typically ≥ 5 years) subject to legal/ethical limits.
• Fabrication, falsification, inappropriate manipulation, or selective reporting constitute misconduct.

6) Human/Animal Ethics & Consent

• Human research requires IRB/ethics approval (board name & approval ID) and informed consent procedures.
• Clinical trials should be prospectively registered (e.g., ClinicalTrials.gov, WHO ICTRP) with registration numbers stated.
• Case reports/identifiable data require explicit patient/guardian consent; personal identifiers must be removed.
• Animal studies must follow recognized welfare guidelines and include ethics approval details.

7) Use of AI Tools

• Generative AI or language models cannot be authors and cannot take responsibility for the work.
• Limited use (e.g., language polishing, code snippets) must be disclosed with tool name/version and scope; authors remain fully accountable.
• Do not upload confidential manuscripts or sensitive data to public AI services. Editors/reviewers must not process submissions via public AI tools.

8) Image Integrity & Figures

• Images must faithfully represent original data. Adjustments (e.g., brightness/contrast) are permitted only if applied uniformly without obscuring or altering information.
• Splicing, duplication, or inappropriate enhancement is prohibited and may lead to rejection, correction, or retraction.

9) Corrections, Retractions & Expressions of Concern

• Authors must promptly notify SHMW of substantive errors found post-publication.
• SHMW follows COPE Retraction Guidelines. Notices (corrigenda, retractions, expressions of concern) are openly accessible and linked to the affected article.

10) Confidentiality & Privacy

• Editors, reviewers, and staff must keep submissions and related communications confidential.
• Personal data are processed in accordance with applicable privacy laws and handled with due care.

11) Diversity, Equity & Inclusion (DEI)

• SHMW promotes equitable inclusion in authorship, editorial roles, and reviewer selection.
• Decisions are based solely on scientific merit and scope fit; discrimination or bias is not tolerated.

12) Complaints, Appeals & Misconduct Investigations

• Appeals must present substantive methodological or interpretive grounds and are considered by an independent editor.
• Allegations of misconduct (e.g., plagiarism, data manipulation, authorship disputes) are investigated per COPE flowcharts; SHMW may contact institutions/funders.
• Possible sanctions: rejection, retraction, time-limited submission bans, and notifications to relevant bodies.
• Submit concerns to: admin1@analysisdata.co.id (cc: shmw@analysisdata.co.id).

13) Editorial Independence

• Editorial decisions are independent of the publisher and free from commercial or political influence.
• Editors/reviewers recuse themselves when conflicts could compromise impartiality.

14) Continuous Improvement

• Policies are periodically reviewed and updated to reflect evolving best practices. Feedback from authors, reviewers, and readers is welcome.